MCD
Clinical trials for MCD explained in plain language.
Never miss a new study
Get alerted when new MCD trials appear
Sign up with your email to follow new studies for MCD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot tested to halt damage in serious kidney diseases
Disease control Recruiting nowThis study is testing an investigational drug called atacicept for several autoimmune kidney diseases, including IgA Nephropathy and Focal Segmental Glomerulosclerosis. It aims to see if weekly injections are safe and can reduce protein in the urine and help preserve kidney funct…
Matched conditions: MCD
Phase: PHASE2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Groundbreaking kidney drug enters human testing phase
Knowledge-focused Recruiting nowThis is the first human study of an experimental oral medication called SK-09, which is being developed for two serious kidney diseases (FSGS and MCD). The trial will test the safety, side effects, and how the drug moves through the body in 72 healthy adult volunteers. Researcher…
Matched conditions: MCD
Phase: PHASE1 • Sponsor: Consun Pharmaceutical Group • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
New system aims to connect kidney patients with right clinical trials
Knowledge-focused Recruiting nowThis study tests a new system that helps match kidney disease patients with clinical trials that might be right for them. It works by analyzing patient information to find trials targeting their specific type of kidney condition. The study also measures how well patients understa…
Matched conditions: MCD
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC